Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?

The evidence base for the benefits of β-blockers in heart failure with reduced ejection fraction (HFrEF) suggests that higher doses are associated with better outcomes. OBJECTIVES: The aim of this study was to report the proportion of patients receiving optimized doses of β-blockers, outcomes, and f...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cardiovasc Nurs
Hlavní autoři: McGinlay, Melanie, Straw, Sam, Byrom-Goulthorp, Rowenna, Relton, Samuel D., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2022
Témata:
ARTICLES: Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613698/
https://ncbi.nlm.nih.gov/pubmed/34321430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCN.0000000000000847
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky